- 专利标题： ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
-
申请号： EP22152178.4申请日： 2013-05-06
-
公开(公告)号： EP4036119A1公开(公告)日： 2022-08-03
- 发明人: SAHIN, Ugur , TÜRECI, Özlem , MITNACHT-KRAUS, Rita , WÖLL, Stefan
- 申请人： Astellas Pharma Inc. , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
- 申请人地址： JP Chuo-ku Tokyo 103-8411 5-1, Nihonbashi-Honcho 2-Chome; DE 55131 Mainz Freiligrathstrasse 12
- 代理机构： Schnappauf, Georg
- 优先权： WOPCT/EP2012/001991 20120509
- 主分类号： C07K16/30
- IPC分类号： C07K16/30 ; A61P37/00
摘要：
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
信息查询
